Geninus

Geninus is a leading South Korean precision medicine company specializing in advanced genomic analysis and bioinformatics. Spun off from the Samsung Genome Institute, the company provides a comprehensive ecosystem for cancer diagnostics and research, including solid tumor profiling, liquid biopsy, and single-cell analysis. Their flagship platforms, such as CancerScan and LiquidScan, are utilized by major medical institutions to guide personalized treatment decisions for oncology patients. Additionally, their Celinus platform offers high-resolution single-cell sequencing services to pharmaceutical companies for target identification and clinical trial biomarker discovery. Geninus is publicly listed on the KOSDAQ and continues to expand its footprint in the global genomics market, particularly in Japan and the United States.